SARS-CoV-2

Bin Tan1, Xueying Liang2, Ahmadullah Ansari3,4

  • 1Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.

PubMed
概括

针对SARS-CoV-2帕帕因类蛋白酶 (PLpro) 的新型共价抑制剂显示出强大的抗病毒活性. 这些化合物显示出对抗不断演变的病毒有前途的药物潜力,包括有利的体内特性.